
1. j trop med hyg. 2014 aug;91(2):412-4. doi: 10.4269/ajtmh.14-0053. epub 2014
jun 2.

glucose-6-phosphate dehydrogenase deficiency a- variant febrile patients in
haiti.

carter te(1), maloy h(2), von fricken m(2), st victor y(2), romain jr(2), okech
ba(2), mulligan cj(2).

author information: 
(1)genetics genomics program, university florida, gainesville, florida;
department anthropology, university florida, gainesville, florida; genetics
institute, university florida, gainesville, florida; department medicinal
chemistry, university florida, gainesville, florida; emerging pathogens
institute, university florida, gainesville, florida; department of
environmental global health, university florida, gainesville, florida;
hospital saint croix, leogane, haiti; blanchard clinic, terre noire, haiti
tamarec@ufl.edu.
(2)genetics genomics program, university florida, gainesville, florida;
department anthropology, university florida, gainesville, florida; genetics
institute, university florida, gainesville, florida; department medicinal
chemistry, university florida, gainesville, florida; emerging pathogens
institute, university florida, gainesville, florida; department of
environmental global health, university florida, gainesville, florida;
hospital saint croix, leogane, haiti; blanchard clinic, terre noire, haiti.

haiti one two remaining malaria-endemic countries caribbean. to
decrease malaria transmission haiti, primaquine recently added the
malaria treatment public health policy. one limitation primaquine that, 
certain doses, primaquine cause hemolytic anemia individuals with
glucose-6-phosphate dehydrogenase (g6pd) deficiency (g6pdd). study, we
genotyped two mutations (a376g g202a), confer common g6pdd
variant west african populations, g6pdd a-. estimated frequency of
g6pdd a- sample febrile patients enrolled on-going malaria study
who represent potential target population primaquine mass drug
administration. found 33 168 individuals carried g6pdd a- allele
(includes a- hemizygous males, a- homozygous heterozygous females) could
experience toxicity treated primaquine. data inform discussions 
safe effective primaquine dosing future malaria elimination strategies
for haiti.

Â© american society tropical medicine hygiene.

doi: 10.4269/ajtmh.14-0053 
pmcid: pmc4125271
pmid: 24891465  [indexed medline]

